US EditionTop 10 U.S. Biopharma Clusters 2025
Addressing analysts earlier this year, executives from Alexandria Real Estate Equities discussed some sobering trends facing biopharma as well as the industry’s enduring strengths, both of which pose challenges for the nation’s largest life sciences-focused real estate investment trust (REIT). Joel S. Marcus, Alexandria’s executive chairman and founder, cited continuing high interest rates; potential restructuring of the NIH into fewer institute…
1 Articles
1 Articles
Top 10 U.S. Biopharma Clusters 2025
Addressing analysts earlier this year, executives from Alexandria Real Estate Equities discussed some sobering trends facing biopharma as well as the industry’s enduring strengths, both of which pose challenges for the nation’s largest life sciences-focused real estate investment trust (REIT). Joel S. Marcus, Alexandria’s executive chairman and founder, cited continuing high interest rates; potential restructuring of the NIH into fewer institute…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
